About Tate & Lyle (LON:BD15)
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company's segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment's product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment's product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries. The Company's portfolio of products includes DOLCIA PRIMA Allulose, PUREFRUIT Monk Fruit Extract, TASTEVA Stevia Sweetener, CLARIA Functional Clean-Label Starches, PROMITOR Soluble Fibre, PromOat Beta Glucan and SODA-LO Salt Microspheres. The Company operates primarily in two industries: corn wet milling and sweeteners. The Company operates a network of corn elevator facilities across the United States Midwest.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolLON:BD15
CUSIPN/A
Phone+44-20-72572100
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins8.87%
Return on Equity18.84%
Return on Assets9.18%
Miscellaneous
EmployeesN/A
Outstanding Shares2,390,000
Tate & Lyle (LON:BD15) Frequently Asked Questions
What is Tate & Lyle's stock symbol?
Tate & Lyle trades on the London Stock Exchange (LON) under the ticker symbol "BD15."
What price target have analysts set for BD15?
9 equities research analysts have issued 12-month target prices for Tate & Lyle's stock. Their predictions range from GBX 630 to GBX 800. On average, they anticipate Tate & Lyle's stock price to reach GBX 685.56 in the next twelve months. View Analyst Ratings for Tate & Lyle.
Who are Tate & Lyle's key executives?
Tate & Lyle's management team includes the folowing people:
- Javed Ahmed, Chief Executive, Executive Director (Age 57)
- Anthony Nicholas Hampton, Chief Financial Officer, Executive Director (Age 50)
- Robert Gibber, Executive Vice President, General Counsel
- Rob Luijten, Executive Vice President - Human Resources
- Rowan Adams, Executive Vice President - Corporate Affairs
- Joan Braca, President - Speciality Food Ingredients
- Pierre Schoumacher, President - Global Operations
- Jim Stutelberg, President - Bulk Ingredients
- Claire-Marie O'Grady, Company Secretary
- Gerard Murphy Ph.D., Non-Executive Chairman of the Board (Age 62)
Has Tate & Lyle been receiving favorable news coverage?
Press coverage about BD15 stock has been trending positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tate & Lyle earned a news sentiment score of 0.44 on Accern's scale. They also gave media coverage about the company an impact score of 47.82 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Tate & Lyle?
Shares of BD15 and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Tate & Lyle's stock price today?
One share of BD15 stock can currently be purchased for approximately GBX 111.50.
How big of a company is Tate & Lyle?
Tate & Lyle has a market capitalization of £2.53 billion.
How can I contact Tate & Lyle?
Tate & Lyle's mailing address is 1 Kingsway, LONDON, WC2B 6AT, United Kingdom. The company can be reached via phone at +44-20-72572100.
MarketBeat Community Rating for Tate & Lyle (BD15)
MarketBeat's community ratings are surveys of what our community members think about Tate & Lyle and other stocks. Vote "Outperform" if you believe BD15 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BD15 will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tate & Lyle (LON:BD15) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for Tate & Lyle in the last 12 months. Their average twelve-month price target is GBX 685.56The high price target for BD15 is GBX 800 and the low price target for BD15 is GBX 630. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.22 | 2.22 | 2.00 | 2.00 |
| Ratings Breakdown: | 1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 685.56 | GBX 685.56 | GBX 713.57 | GBX 709.29 |
Tate & Lyle (LON:BD15) Consensus Price Target History
Tate & Lyle (LON:BD15) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
Tate & Lyle (LON:BD15) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Tate & Lyle (LON BD15) Insider Trading and Institutional Ownership History
Tate & Lyle (LON BD15) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Tate & Lyle (LON BD15) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Grab Tate & Lyle plc (LON:TATE) Today With A Solid 5.01% Dividend Yield
finance.yahoo.com - April 24 at 3:44 PM |
 | Berenberg Bank Analysts Give Tate & Lyle (BD15) a GBX 730 Price Target
www.americanbankingnews.com - April 8 at 9:10 PM |
| Tate & Lyle PLC (BD15) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 5 at 1:36 AM |
| Tate & Lyle (BD15) Given a GBX 695 Price Target at Goldman Sachs
www.americanbankingnews.com - March 25 at 10:29 AM |
 | Increasing Demand for Insoluble Dietary Fibres in Pharmaceuticals and Dietary Supplements to be Observed Throughout the Period of Forecast
globenewswire.com - March 21 at 3:34 PM |
| How Financially Strong Is Tate & Lyle plc (LON:TATE)?
finance.yahoo.com - March 19 at 3:33 PM |
 | Global Citric Acid Market Opportunities 2018: Jungbunzlauer Suisse AG, COFCO Biochemical (Anhui) Co. Ltd.
www.marketwatch.com - March 19 at 10:43 AM |
| Tate & Lyle PLC (BD15) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 11 at 1:38 AM |
| Tate & Lyle Names HORN Its U.S. Distributor for the Nutrition Industry
finance.yahoo.com - March 1 at 3:48 PM |
| Tate & Lyle (BD15) Given a GBX 630 Price Target at Kepler Capital Markets
www.americanbankingnews.com - February 18 at 5:54 PM |
 | DIRECTOR DEALINGS: PCA To Outgoing Tate & Lyle Boss Buy Shares
www.morningstar.co.uk - February 15 at 3:39 PM |
 | Citric Acid Market Size Worth $3.83 Billion By 2025 | CAGR: 4.9%: Grand View Research, Inc.
www.finanznachrichten.de - February 14 at 8:25 AM |
| Tate & Lyle PLC (BD15) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - February 14 at 1:28 AM |
| DIRECTOR DEALINGS: Tate & Lyle Chairman's Wife Buys Shares
www.morningstar.co.uk - February 13 at 5:14 PM |
| Tate & Lyle (BD15) Given a GBX 650 Price Target at Deutsche Bank
www.americanbankingnews.com - February 13 at 12:58 AM |
| Tate & Lyle (BD15) PT Set at GBX 655 by Berenberg Bank
www.americanbankingnews.com - February 11 at 6:22 AM |
| Societe Generale Analysts Give Tate & Lyle (BD15) a GBX 680 Price Target
www.americanbankingnews.com - February 11 at 12:12 AM |
| Tate & Lyle (BD15) PT Set at GBX 670 by Credit Suisse Group
www.americanbankingnews.com - February 8 at 2:40 PM |
| Tate & Lyle (BD15) Given a GBX 660 Price Target by Kepler Capital Markets Analysts
www.americanbankingnews.com - February 8 at 6:48 AM |
| Tate & Lyle plc (LON:TATE) Should Be In Your Dividend Portfolio, Here’s Why
finance.yahoo.com - January 24 at 8:40 AM |
| Tate & Lyle PLC (BD15) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 20 at 1:28 AM |
| Tate & Lyle PLC (BD15) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 26 at 1:38 AM |
| Can Tate & Lyle plc (LON:TATE) Continue To Outperform Its Industry?
finance.yahoo.com - December 15 at 11:29 AM |
 | Tate & Lyle's (TATYF) CEO Javed Ahmed on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - November 18 at 9:21 PM |
| Global Chelating Agents Industry Analysis, Size, Market share, Growth, Trend and Forecast 2022
www.marketwatch.com - November 16 at 9:47 PM |
| Tate & Lyle PLC (BD15) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 1:40 AM |
| Kepler Capital Markets Reiterates GBX 690 Price Target for Tate & Lyle PLC (BD15)
www.americanbankingnews.com - November 5 at 2:26 PM |
| Tate & Lyle, PLC 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - November 5 at 4:06 AM |
| Goldman Sachs Group, Inc. (The) Analysts Give Tate & Lyle PLC (BD15) a GBX 660 Price Target
www.americanbankingnews.com - November 3 at 12:24 PM |
| Estimating The Intrinsic Value Of Tate & Lyle plc (LSE:TATE)
finance.yahoo.com - November 3 at 8:54 AM |
 | The global functional ingredients market is expected to be valued at USD 96.1 billion by 2026, growing at a CAGR of 5.9%
www.bizjournals.com - November 1 at 10:06 PM |
| Tate & Lyle PLC (BD15) Given a GBX 660 Price Target by Kepler Capital Markets Analysts
www.americanbankingnews.com - October 27 at 10:34 AM |
| Global Edible Films and Coatings Market to touch US$ 3,336.7 Mn by 2027
globenewswire.com - October 24 at 6:23 PM |
| Tate & Lyle PLC (BD15) Given a GBX 750 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - October 23 at 6:08 AM |
| Brown Sugar Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022
finance.yahoo.com - October 16 at 5:15 PM |
| Tate & Lyle PLC (BD15) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 12 at 2:44 AM |
| Functional Ingredients Market Size Worth $96.1 Billion by 2026: Grand View Research, Inc.
www.marketwatch.com - October 5 at 2:36 PM |
 | Porvair Appoints Diploma Chair John Nicholas As Chairman Designate
www.lse.co.uk - September 28 at 8:27 AM |
| How Sweet Is Brexit? U.K. Sugar Giants Split Over Trade Outlook
finance.yahoo.com - September 12 at 8:22 PM |
| Should You Buy Tate & Lyle plc (LSE:TATE) At This PE Ratio?
finance.yahoo.com - September 11 at 5:04 PM |
| Modified Starch - Global Market Outlook (2017-2023)
www.bizjournals.com - September 1 at 12:40 AM |
| Tate & Lyle PLC (BD15) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 23 at 3:32 AM |
| Goldman Sachs Group, Inc. (The) Analysts Give Tate & Lyle PLC (LON:BD15) a GBX 660 Price Target
www.americanbankingnews.com - July 31 at 6:32 AM |
| Tate & Lyle PLC (LON:BD15) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 29 at 2:34 AM |
| Tate & Lyle PLC (BD15) Given a GBX 725 Price Target at Deutsche Bank AG
www.americanbankingnews.com - July 28 at 10:25 AM |
| Goldman Sachs Group, Inc. (The) Analysts Give Tate & Lyle PLC (LON:BD15) a GBX 650 Price Target
www.americanbankingnews.com - July 10 at 6:10 AM |
| Deutsche Bank AG Analysts Give Tate & Lyle PLC (LON:BD15) a GBX 725 Price Target
www.americanbankingnews.com - July 7 at 10:38 AM |
| Tate & Lyle 2017 pretax profit rises 85%
www.marketwatch.com - May 25 at 4:52 PM |
| Egg Replacers Market Worth 1283.0 Million USD by 2022
www.marketwatch.com - May 23 at 10:58 AM |
 | How sugar reveals our Brexit future
www.msn.com - March 28 at 3:51 PM |
Tate & Lyle (LON:BD15) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Tate & Lyle (LON BD15) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
